Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Gurnee. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Gurnee at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn's Disease (CD). The primary objective of this study is to assess the efficacy of different doses of SAR441566 compared with placebo in participants with moderate to severe CD. This study will include a screening period of 4 weeks (+7 calendar days if needed), followed by the Main Study (MS) treatm
Sponsor: Sanofi
Check if you qualify for this crohn's disease clinical trial in Gurnee, IL
If you're searching for crohn's disease treatment options in Gurnee, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gurnee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.